Back to search

Virginia Commonwealth University

Overcoming Mechanisms of Acquired and Innate Doxorubicin Resistance Using Nanomedicine and Tumor-Associated Macrophage Immunotherapy

Abstract

dc:description.abstract

ABSTRACT Overcoming Mechanisms of Acquired and Innate Doxorubicin Resistance Using Nanomedicine and Tumor-Associated Macrophage Immunotherapy By Rashed M. Almuqbil, Pharm.D. Director: Sandro R.P. da Rocha, PhD Cancer is a leading cause of death worldwide. The available treatment for solid tumors may include surgery, radiotherapy, immunotherapy, and chemotherapy or a combination of all those regimens. Chemotherapy is widely used in the treatment of both lung cancers and breast cancer, including metastases, irrespective of type and stage. The poor rates of survival can be attributed to late diagnosis, and due to the development of acquired and innate chemoresistance. Lung tumors are intrinsically resistant to chemotherapy, thus requiring the development of predictive biomarkers to personalize chemotherapeutic agents. In breast cancer patients, continuous exposure to a single chemotherapeutic agent can lead to (acquired resistance) such as multidrug resistance. Here, we formed a realistic in vitro model for the screening of chemotherapy, as the tumor stroma is composed of extracellular matrix, fibroblast, as well as how it is able to grow in a 3D manner. We described the formulation of a 4th generation PAMAM dendrimer and evaluated its efficacy and penetration through a 3D model of single and coculture spheroids, as a strategy to overcome doxorubicin’s resistance. Also, the efficacy of DOX in vivo as a single and in combination with the immunotherapy PLX3397 was evaluated, to modulate the tumor microenvironment in a syngeneic orthotopic Balb/c mice model by repolarizing M2 macrophages toward more M1 like macrophages, a potential strategy to enhance the innate immunity to fight cancer cells and overcome resistance and diminish distant metastasis.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy
Level thesis:degree_level
Dissertation
Discipline thesis:degree_discipline
Pharmaceutical Sciences

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Almuqbil, Rashed M
  • <p>https://orcid.org/0000-0003-2991-620X</p>
Contributors dc:contributor
  • Sandro R.P. da Rocha

Subjects

dc:subject × 12

Rights

dc:rights
Statement dc:rights
  • © The Author

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
Virginia Commonwealth University
Base URL
scholarscompass.vcu.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Almuqbil, Rashed M; <p>https://orcid.org/0000-0003-2991-620X</p>. Overcoming Mechanisms of Acquired and Innate Doxorubicin Resistance Using Nanomedicine and Tumor-Associated Macrophage Immunotherapy. Dissertation thesis, https://doi.org/10.25772/1KWY-J409